“…This nationwide cohort study used data from the ‘Dutch Gynecological Oncology Audit’ (DGOA). The DGOA is a population-based and prospectively maintained quality registry, facilitated by the Dutch Institute for Clinical Auditing, that contains reliable, detailed clinical data of all patients with any form of therapy for ovarian, vulvar, endometrial, and cervical cancer in the Netherlands (population 17.3 million) [ 9 , 10 ]. Since January 2014, the DGOA has been a mandatory registry for all Dutch hospitals treating gynecological malignancies.…”